NexImmune, Inc. (NEXI)
Total Valuation
NexImmune has a market cap or net worth of $7.18 million. The enterprise value is -$1.27 million.
Market Cap | 7.18M |
Enterprise Value | -1.27M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NexImmune has 1.18 million shares outstanding. The number of shares has increased by 7.32% in one year.
Shares Outstanding | 1.18M |
Shares Change (YoY) | +7.32% |
Shares Change (QoQ) | +0.45% |
Owned by Insiders (%) | 21.80% |
Owned by Institutions (%) | 7.97% |
Float | 753,163 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.87 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.07.
Current Ratio | 1.66 |
Quick Ratio | n/a |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -216.30% and return on invested capital (ROIC) is -506.31%.
Return on Equity (ROE) | -216.30% |
Return on Assets (ROA) | -157.00% |
Return on Capital (ROIC) | -506.31% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.99M |
Employee Count | 22 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.20% in the last 52 weeks. The beta is 1.93, so NexImmune's price volatility has been higher than the market average.
Beta (1Y) | 1.93 |
52-Week Price Change | -44.20% |
50-Day Moving Average | 7.61 |
200-Day Moving Average | 5.88 |
Relative Strength Index (RSI) | 38.47 |
Average Volume (30 Days) | 2,259,316 |
Short Selling Information
The latest short interest is 35,212, so 2.98% of the outstanding shares have been sold short.
Short Interest | 35,212 |
Short Previous Month | 15,758 |
Short % of Shares Out | 2.98% |
Short % of Float | 4.68% |
Short Ratio (days to cover) | 0.01 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -44.85M |
Pretax Income | -43.88M |
Net Income | -43.88M |
EBITDA | -42.26M |
EBIT | -43.88M |
Earnings Per Share (EPS) | -$42.15 |
Balance Sheet
The company has $9.06 million in cash and $604,638 in debt, giving a net cash position of $8.45 million or $7.14 per share.
Cash & Cash Equivalents | 9.06M |
Total Debt | 604,638 |
Net Cash | 8.45M |
Net Cash Per Share | $7.14 |
Equity / Book Value | 8.25M |
Book Value Per Share | 6.98 |
Working Capital | 4.12M |
Cash Flow
In the last 12 months, operating cash flow was -$36.72 million and capital expenditures -$187,655, giving a free cash flow of -$36.91 million.
Operating Cash Flow | -36.72M |
Capital Expenditures | -187,655 |
Free Cash Flow | -36.91M |
FCF Per Share | -$35.22 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NexImmune does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.32% |
Shareholder Yield | -7.32% |
Earnings Yield | -611.39% |
FCF Yield | -514.29% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 19, 2023. It was a reverse split with a ratio of 1:25.
Last Split Date | Oct 19, 2023 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |